Core Laboratories N.V. (NYSE:CLB) received a $100.00 price objective from equities researchers at Cowen and Company in a research note issued to investors on Friday. The firm currently has a “hold” rating on the oil and gas company’s stock. Cowen and Company’s price target would suggest a potential upside of 6.09% from the stock’s current price.

Other equities research analysts also recently issued reports about the stock. Royal Bank Of Canada set a $145.00 price objective on shares of Core Laboratories N.V. and gave the stock a “buy” rating in a research note on Saturday, June 17th. ValuEngine upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Piper Jaffray Companies set a $97.00 price objective on shares of Core Laboratories N.V. and gave the stock a “hold” rating in a research note on Wednesday, July 26th. Finally, Zacks Investment Research upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, September 12th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $111.10.

Core Laboratories N.V. (CLB) traded down 1.80% during trading on Friday, hitting $94.26. 509,425 shares of the stock were exchanged. Core Laboratories N.V. has a 52 week low of $86.55 and a 52 week high of $125.83. The firm has a 50-day moving average of $93.41 and a 200-day moving average of $102.87. The stock has a market capitalization of $4.16 billion, a price-to-earnings ratio of 57.83 and a beta of 1.64.

Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.01. The firm had revenue of $163.90 million for the quarter, compared to the consensus estimate of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.35 earnings per share. Equities research analysts anticipate that Core Laboratories N.V. will post $1.99 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Core Laboratories N.V. (CLB) PT Set at $100.00 by Cowen and Company” was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/06/core-laboratories-n-v-clb-pt-set-at-100-00-by-cowen-and-company.html.

Several hedge funds have recently bought and sold shares of CLB. BlackRock Inc. lifted its holdings in shares of Core Laboratories N.V. by 3,736.4% in the first quarter. BlackRock Inc. now owns 1,598,608 shares of the oil and gas company’s stock worth $184,672,000 after acquiring an additional 1,556,938 shares during the last quarter. Sustainable Growth Advisers LP lifted its holdings in shares of Core Laboratories N.V. by 36.9% in the second quarter. Sustainable Growth Advisers LP now owns 2,345,271 shares of the oil and gas company’s stock worth $237,505,000 after acquiring an additional 632,263 shares during the last quarter. WCM Investment Management CA lifted its holdings in shares of Core Laboratories N.V. by 7.3% in the second quarter. WCM Investment Management CA now owns 4,433,175 shares of the oil and gas company’s stock worth $448,948,000 after acquiring an additional 303,073 shares during the last quarter. Neuberger Berman Group LLC lifted its holdings in shares of Core Laboratories N.V. by 6,220.7% in the second quarter. Neuberger Berman Group LLC now owns 251,313 shares of the oil and gas company’s stock worth $25,450,000 after acquiring an additional 247,337 shares during the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of Core Laboratories N.V. by 59.0% in the second quarter. Sei Investments Co. now owns 665,817 shares of the oil and gas company’s stock worth $67,426,000 after acquiring an additional 247,042 shares during the last quarter.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.